期刊文献+

糖尿病足与糖尿病下肢动脉病变及预后的相关性研究 被引量:4

The correlation research of diabetic foot with peripheral arterial disease and prognosis
下载PDF
导出
摘要 目的探讨糖尿病足与下肢动脉病变及预后的相关性。方法以2009年2月至2012年6月收治的75例糖尿病患者作为研究对象,将其中35例糖尿病足患者列为DF组,将40例非糖尿病足患者列为非DF组。比较两组患者下肢动脉病变的发生情况,随访1年根据患者是否截肢分为截肢组和非截肢组,并对两组患者的一般情况和相关因素进行统计分析。结果 DF组患者下肢动脉病变的发病率明显高于非DF组,且DF组并发重度下肢动脉病变的患者显著多于非DF组,随访1年后,DF组35例患者中截肢8例,截肢率22.9%,其中糖尿病合并感染和既往有截肢史是糖尿病足患者1年内发生截肢的独立危险因素。结论经双下肢彩色多普勒检查并评定为严重下肢动脉病变以及PAD评分较高的糖尿病患者其1年内病发糖尿病足的几率较高,与合并感染以及既往有截肢史同为影响其预后的独立危险因素,临床可据此及早对伴有上述危险因素的患者给予针对性的治疗。 Objective To discuss the correlation of diabetic foot with peripheral arterial disease and prognosis. Methods 75 cases of diabetic patients in our hospital from February 2009 to June 2012 were included into this study and treated as the research objects. These objects included 35 patients with diabetic foot, classified as the DF group, and 40 cases of patients not with diabetic foot as the no - DF group. To compare occurrence of peripheral arterial disease in patients of two groups. All patients were followed up for 1 year. According to whether patients with am- putation, these patients were divided into the amputation group and the non amputation group. The general situation and related factors of patients in two groups were compared and analyzed. Results The incidence of peripheral arterial disease in patients of two groups had obvious differences. The patients with severe peripheral arterial disease in the DF group were significantly more than that in the no - DF group. After 1 year following up, 8 cases had amputation in 35 cases of the DF group, the amputation rate was 22.9%. Patients combined with diabetic foot, infection and the history of amputation are independent risk factors for amputation occurred in a year. Conclusion The patients with assessment through the color Doppler ultrasonography of both lower extremities of severe lower limb arterial lesions, higher PAD score had higher invasion probability of diabetic foot in 1 year. They were the independent risk factors for the prognosis as with combined infection, history of amputation. The physician should give targeted therapy to patients with these risk factors as soon as possible.
出处 《临床和实验医学杂志》 2014年第11期930-932,共3页 Journal of Clinical and Experimental Medicine
关键词 糖尿病足 下肢动脉病变 预后 Diabetic foot Peripheral arterial disease Prognosis
  • 相关文献

参考文献13

  • 1Ambrosch A, Halevy D, Fwity B, et al. Effect of daptomycin on local interleukin - 6, matrix metalloproteinase - 9, and metallopeptidase in- hibitor 1 in patients with MRSA - infected diabetic foot [J]. Int J Low Extrem Wounds, 2013,12 (2) : 100 - 105.
  • 2王玉珍,许樟荣.糖尿病足病的诊断与治疗进展[J].实用老年医学,2013,27(4):276-279. 被引量:22
  • 3Rubio JA, Aragon - Sanchez J, Jimenez S, et al. Reducing major lower extremity amputations after the introduction of a muhidisciplinary team for the diabetic foot[ J]. Int J Low Extrem Wounds, 2014,13 ( 1 ) :22 - 26.
  • 4王爱红,许樟荣,纪立农.中国城市医院糖尿病截肢的临床特点及医疗费用分析[J].中华医学杂志,2012,92(4):224-227. 被引量:110
  • 5Huang KC, Chen CC, Su YC, et al. The Relationship between Stasis - Stagnation Constitution and Peripheral Arterial Disease in Patients with Type 2 Diabetes [ J]. Evid Based Complement Alternat Med, 2014: 903798.
  • 6Pradeepa R, Chella S, Surendar J, et al. Prevalence of peripheral vas- cular disease and its association with carotid intima - media thickness and arterial stiffness in type 2 diabetes: The Chennai Urban Rural Epidemiology Study ( CURES 111 ) [ J]. Diab Vase Dis Res, 2014, Epub ahead of print.
  • 7彭欣,银浩强,徐蓉娟,肖沪生.糖尿病下肢动脉病变的影响因素分析[J].安徽医药,2009,13(6):619-621. 被引量:3
  • 8Ahhouse AD, Abbott JD, Forker AD, et al. Risk Factors for Incident Peripheral Arterial Disease in Type 2 Diabetes : Results From the Bypass Angioplasty Revascularization Investigation 2 Diabetes Trial[J]. Diabetes Care, 2014,37(5) :1346 - 1352.
  • 9Prompers L, Schaper N, Apelqvist J, et al. Prediction of outcome in in- dividuals with diabetic foot ulcers:focus on the differences between indi- viduals with and without peripheral arterial disease [ J ]. Diabetologia, 2008,51 ( 5 ) :747 - 755.
  • 10Driver VR, Fabbi M, Lavery LA, et al. The costs of diabetic foot : the economic case for the limb salvage team[ J]. J Am Podiatr Med Assoc, 2010,100(5) :335 -341.

二级参考文献30

  • 1胡萍香,张壮凤,陈芸,欧伟萍.彩色多普勒超声诊断老年糖尿病下肢动脉病变[J].中国医学影像技术,2005,21(7):1042-1044. 被引量:15
  • 2王爱红,赵湜,李强,王鹏华,严励,杜玉茗,卞茸文,王战建,毛季萍,肖正华,马学毅,林少达,陈国昌,周迎生,许樟荣.中国部分省市糖尿病足调查及医学经济学分析[J].中华内分泌代谢杂志,2005,21(6):496-499. 被引量:274
  • 3张步林,朱家安,胡兵,冯亮,罗兰.糖尿病下肢动脉闭塞发生部位及侧支血管形成的超声表现[J].中国医学影像技术,2007,23(2):229-231. 被引量:28
  • 4Oka RK,Sanders MG.The impact of type 2 diabetes and peripheral arterial disease on quality of life[J].J Vasc Nurs,2005,23(2):61-66;quiz 67-8.
  • 5Dormandy JA,Rutherford RB.Management of peripheral arterial disease (PAD).TASC Working Group.TransAtlantic Inter-Society Consensus (TASC)[J].J Vasc Surg,2000,31(1 Pt 2):S1-296.
  • 6Hiatt WR.Medical treatment of peripheral arterial disease and claudication.N Engl J Med,2001,344(21):1608-21.
  • 7Dolan NC,Liu K,Criqui MH,et al.Peripheral artery disease,diabetes,and reduced lower extremity functioning[J].Diabetes Care,2002,25(1):113-20.
  • 8Criqui MH.Peripheral arterial disease-epidemiological aspects[J].Vasc Med,2001,6(3 Suppl):3-7.
  • 9Murabito JM,D'Agostino RB,Silbershatz H,et al.Intermittent claudication.A risk profile from The Framingham Heart Study[J].Circulation,1997,96(1):44-9.
  • 10American Diabetes Association.Peripheral arterial disease in people with diabetes[J].Diabetes Care,2003,26(12):3333-41.

共引文献133

同被引文献51

  • 1Lipsky BA,Berend AR,Comia PB,et al, 2012 Infectious diseases society of america clinical practice guideline for the diagnosis and treatment of diabetic foot infectionsa [J]. Clinical Infectious Diseases, 2012,54(12) : 132-173.
  • 2Zoungas S, de fects of routine cose control on Galan BE,Ninomiya T,et al. Combined el- blood pressure lowering and intensive glu- macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial [J]. Diabetes Care, 2009,32 (11) : 2068- 2074.
  • 3Chou CK,Weng SW,Chang HW,et al. Analysis of tradi- tional and nontraditional risk factors for peripheral arterial disease in elderly type 2 diabetic patients in Taiwan[J]. Diabetes Res Clin Pract, 2008,81 (3) : 331 ~337.
  • 4Coppola G, Corrado E, Muratori I,et al. Increased levels of C-reactive protein and fibrinogen influence the risk of vascular events in patients with NIDDM [J]. Int J Cardi- ol, 2006,6( 1 ) : 16-20.
  • 5Bosevski M, Bosevska G, Stojanovska L. Influence of fib- rinogen and C-RP on progression of peripheral arterial disease in type 2 diabetes:a preliminary report [J]. Car- diovasc Diabetol,2013,12:29.
  • 6Lau DH, Huynh LT, Chew DP, et al. Prognostic impact of types of atrialfibrillation in acute coronary syndromes [J]. Am J Cardiol, 2001,4(10) : 1317-1323.
  • 7Guo M, Daines D,Tang J, et al. Fibrinogen-gamma C - terminal fragments induce endothelial barrier dysfunction and microvascular leak via integrin-mediated and RhoA-dependent mechanism [J]. Arterioscler Thromb Vas Biol, 2009,29(3) : 394-4001.
  • 8郭芳,刘俊田.纤维蛋白(原)与动脉粥样硬化关系的研究进展[J].生理科学进展,2009,40(2):169-171. 被引量:18
  • 9刘萍,王丽萍.纤维蛋白原与2型糖尿病下肢血管病变相关性分析[J].陕西医学杂志,2011,40(1):85-86. 被引量:6
  • 10李翔.2011年国际糖尿病足工作组有关糖尿病足感染治疗的特别指南[J].中华损伤与修复杂志(电子版),2011,6(4):8-8. 被引量:13

引证文献4

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部